4'-((1R,3r)-3-((R)-2-methylpyrrolidin-1-yl)cyclobutyl)biphenyl-4-carbonitrile

ID: ALA4516622

PubChem CID: 11973711

Max Phase: Preclinical

Molecular Formula: C22H24N2

Molecular Weight: 316.45

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@@H]1CCCN1[C@H]1C[C@H](c2ccc(-c3ccc(C#N)cc3)cc2)C1

Standard InChI:  InChI=1S/C22H24N2/c1-16-3-2-12-24(16)22-13-21(14-22)20-10-8-19(9-11-20)18-6-4-17(15-23)5-7-18/h4-11,16,21-22H,2-3,12-14H2,1H3/t16-,21-,22-/m1/s1

Standard InChI Key:  DQUUMUHVZGIZNI-NPFVIJTESA-N

Molfile:  

 
     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
   22.0191   -3.1624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0179   -3.9898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7327   -4.4026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4491   -3.9893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4462   -3.1587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7309   -2.7497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1562   -2.7449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8724   -3.1564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5849   -2.7419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5821   -1.9161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8611   -1.5064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1517   -1.9233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3060   -4.3985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5093   -4.1843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2952   -4.9811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0919   -5.1952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5803   -5.3930    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8279   -5.0589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2754   -5.6716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6874   -6.3864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4944   -6.2154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6563   -4.2520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2914   -1.5018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0038   -1.0857    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  5  7  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 13  1  0
 13  2  1  1
 15 17  1  6
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 17  1  0
 18 22  1  1
 23 24  3  0
 10 23  1  0
M  END

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 316.45Molecular Weight (Monoisotopic): 316.1939AlogP: 4.96#Rotatable Bonds: 3
Polar Surface Area: 27.03Molecular Species: BASEHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.06CX LogP: 4.85CX LogD: 2.25
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.80Np Likeness Score: -0.45

References

1. Łażewska D, Kaleta M, Schwed JS, Karcz T, Mogilski S, Latacz G, Olejarz A, Siwek A, Kubacka M, Lubelska A, Honkisz E, Handzlik J, Filipek B, Stark H, Kieć-Kononowicz K..  (2017)  Biphenyloxy-alkyl-piperidine and azepane derivatives as histamine H3 receptor ligands.,  25  (20): [PMID:28797771] [10.1016/j.bmc.2017.07.058]

Source